H.R. 7528
IntroducedGAP Supply Act
Plain-language analysis
Not yet analyzed.
A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text below and the official source are the record.
Full text of the bill
Official source on Congress.gov ↗[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7528 Introduced in House (IH)]
<DOC>
119th CONGRESS 2d Session H. R. 7528
To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 12, 2026
Mr. Carter of Georgia introduced the following bill; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Growing America's Pharmaceutical Supply Act'' or the ``GAP Supply Act''.
SEC. 2. PROVIDING FOR A TAIL PERIOD FOR OUTSOURCING FACILITIES TO COMPOUND AND DISTRIBUTE DRUGS IN SHORTAGE.
Section 503B of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353b) is amended--
(1) in subsection (a)(2)(A)(ii), by striking ``at the time'' and inserting ``within 180 calendar days''; and
(2) in subsection (d)(2)(A), by striking ``at the time'' and inserting ``within 180 calendar days''. <all>